洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

【ChiCTR-OIC-16007974】Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

查看原文
立即下载
基本信息
登记号

ChiCTR-OIC-16007974

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2016-02-22

临床申请受理号

/

靶点

/

适应症

乳腺癌

试验通俗题目

Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

试验专业题目

Ultrasound-guided Multi-level Thoracic Paravertebral Block at three levels (T1, T3, and T5) in Combination with a pectoral nerve block for surgical anaesthesia during major breast cancer surgery: A Prospective Feasibility study

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

To evaluate the feasibility of using 3 paravertebral injections (3m-TPVB) at T1, T3 and T5 instead of the traditional 6 injections (at T1 to T6)that are performed in combination with a PECS block for surgical anesthesia in patients undergoing major breast cancer surgery.

试验分类
请登录查看
试验类型

单臂

试验分期

Ⅳ期

随机化

NA

盲法

/

试验项目经费来源

Department of Anaesthesia & Intensive Care, CUHK

试验范围

/

目标入组人数

30

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

Adult patients, ASA physical status I-III, aged between 30 to 80 years scheduled to undergo modified radical mastectomy (MRM) or mastectomy with sentinel lymph node biopsy will be recruited.；

排除标准

Patient refusal, ASA physical status >III, BMI > 35kg/m2, spinal deformity, previous spine surgery, pregnancy, coagulopathy, allergy to local anesthetic drugs, and skin infection at the site of needle insertion will be excluded.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Department of Anaesthesia & Intensive Care, CUHK

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Department of Anaesthesia & Intensive Care, CUHK的其他临床试验

更多

Prince of Wales Hospital, CUHK的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品

同适应症药物临床试验

更多